PROGENIKA BIOPHARMA, S.A.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 11114
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 4443
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 396
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C07K PEPTIDES 1135

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0234,896 LATERAL FLOW IMMUNOASSAYS FOR THE DETECTION OF ANTIBODIES AGAINST BIOLOGICAL DRUGSJul 27, 15Aug 17, 17[G01N]
2016/0305,963 TRANSGENIC ANIMAL MODEL OF MOOD DISORDERSJun 21, 16Oct 20, 16[C12Q, G01N]
2015/0376,708 PROBES AND METHODS FOR DETERMINING THE PRESENCE OR ABSENCE OF GENETIC SEGMENTSSep 10, 15Dec 31, 15[C12Q, G06F]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9637788 Discrimination of blood type variantsJun 14, 12May 02, 17[C12Q, C12P]
9359643 Discrimination of blood type variantsMar 08, 13Jun 07, 16[C07H, C12Q, C12P]
9165108 Probes and methods for determining the presence or absence of genetic segmentsJun 16, 11Oct 20, 15[C12Q, G06F]
9109257 Prognostic methodJul 12, 07Aug 18, 15[A61K, C12Q, C12P]
8712696 Methods of prognosing a rheumatoid arthritis remission phenotypeJul 12, 07Apr 29, 14[G06F]
8669049 Method and device for the detection of mutations in isolated gene sequences of the low-density lipoprotein receptor (LDL-r) which is associated with familial hypercholesterolemiaJan 21, 04Mar 11, 14[C07H, C12Q, C12P]
8153363 Methods and products for in vitro genotypingJul 07, 09Apr 10, 12[C12Q]
7914990 Methods and products for in vitro genotypingJan 12, 06Mar 29, 11[C12Q]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0060,696 METHOD FOR THE IDENTIFICATION BY MOLECULAR TECHNIQUES OF GENETIC VARIANTS THAT ENCODE NO D ANTIGEN (D-) AND ALTERED C ANTIGEN (C+W)AbandonedNov 11, 15Mar 03, 16[A61K, C12Q]
2016/0010,160 PROGNOSTIC METHODAbandonedJul 13, 15Jan 14, 16[C12Q]
2013/0280,171 METHOD TO OPTIMIZE THE TREATMENT OF PATIENTS WITH BIOLOGICAL DRUGSAbandonedDec 22, 11Oct 24, 13[A61K]
2013/0263,294 MARKERS FOR JOINT DISPLASIA, OSTEOARTHRITIS AND CONDITIONS SECONDARY THERETOAbandonedSep 19, 11Oct 03, 13[C12Q]
2013/0184,167 GENETIC MARKERS FOR THE PROGNOSIS OF MULTIPLE SCLEROSISAbandonedDec 18, 08Jul 18, 13[C12Q, G06F]
2012/0172,239 METHOD FOR THE IDENTIFICATION BY MOLECULAR TECHNIQUES OF GENETIC VARIANTS THAT ENCODE NO D ANTIGEN (D-) AND ALTERED C ANTIGEN (C+W)AbandonedDec 28, 11Jul 05, 12[C07H, C12Q, G01N, C40B]
2011/0098,191 IN VITRO METHODS FOR DETECTING RENAL CANCERAbandonedSep 07, 10Apr 28, 11[C12Q, G01N, C40B]
2011/0045,997 METHOD AND PRODUCT FOR "IN VITRO" GENOTYPING WITH APPLICATIONS IN ANTI-AGEING MEDICINEAbandonedFeb 21, 08Feb 24, 11[C07H, G06F, C40B]
2008/0274,968 IN VITRO METHODS FOR DETECTING RENAL CANCERAbandonedApr 16, 08Nov 06, 08[A61K, C12Q, C12N, G01N, A61P]
2008/0113,347 Method for the in Vitro Diagnosis and Prognosis of Demyelinating Diseases, and for the Development of Drugs Against Demyelinating DiseasesAbandonedDec 28, 04May 15, 08[C07H, C12Q]
2008/0015,143 In Vitro Methods for Detecting Renal CancerAbandonedJun 30, 04Jan 17, 08[A61K, C12Q, C12N, G01N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.